RGAVX | VCRCX | RGAVX / VCRCX | |
Total Expense Ratio | 1.30 | 2.08 | 63% |
Annual Report Gross Expense Ratio | 1.42 | 2.10 | 68% |
Fund Existence | 9 years | 6 years | - |
Gain YTD | 9.603 | 7.059 | 136% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116M | 882M | 13% |
Annual Yield % from dividends | 3.56 | 0.77 | 460% |
Returns for 1 year | 14.98 | 15.54 | 96% |
Returns for 3 years | -1.05 | 4.47 | -23% |
Returns for 5 years | 66.28 | 56.88 | 117% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPBO | 29.03 | 0.05 | +0.17% |
SPDR® Portfolio Corporate Bond ETF | |||
PSFF | 28.71 | 0.04 | +0.14% |
Pacer Swan SOS Fund of Funds ETF | |||
PTBD | 20.13 | N/A | +0.02% |
Pacer Trendpilot US Bond ETF | |||
FLSW | 35.52 | -0.21 | -0.58% |
Franklin FTSE Switzerland ETF | |||
BIS | 18.95 | -0.73 | -3.71% |
ProShares UltraShort Nasdaq Biotech |